Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

UFS Rector takes three months sabbatical leave
2008-05-05

The Rector of the University of the Free State (UFS), Prof. Frederick Fourie, has announced that he will be taking three months sabbatical leave as from Thursday, 8 May 2008.

Prof. Fourie recently made the request for sabbatical leave to the Chairperson of the UFS Council, Judge Faan Hancke. The request was approved given the fact that Prof. Fourie has occupied a number of demanding top-management posts for almost nine years, during which time he had to manage a number of major changes at the UFS.

According to Prof. Fourie, he originally wanted to go on sabbatical leave in the second half of 2007 before the start of his second term as rector, but it was not possible at that stage.

He was last on sabbatical in 1996 before he became Dean of the Faculty of Economic and Management Sciences in 1997 and Vice-Rector: Academic Operations in 1999.

He could not take his next five-yearly leave because in the post of vice-rector he was tasked with leading the financial-turnaround strategy for the UFS from the year 2000 and had to act as rector when the previous rector, Prof. Stef Coetzee, was on sick leave. Since being inaugurated as rector in 2003, there was also no opportunity to take leave as a result of the many key projects and urgent initiatives.

The Vice-Rector: Academic Operations and vice-chairperson of the Senate, Prof. Teuns Verschoor, will be the acting rector. Management processes and decision-making will continue as normal under the leadership of the acting rector together with the Executive Committee of the Executive Management (Exco) and the Executive Management. This applies to the decision about the future of the Reitz Residence as well as the continuing implementation of the policy on diversity in student residences.

According to Judge Hancke it was important that Prof. Fourie took sabbatical leave in the light of the long period he has been at the forefront of very demanding changes. There are many challenges that still lie ahead.

During his leave Prof. Fourie will be involved with the Higher Education South Africa (HESA) investigation into diversity and racism on campuses, with research and a national conference on institutional culture, as well as the Association of Commonwealth Universities (ACU) benchmarking project and its conference in Australia at the end of August 2008.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept